ARCHIVES

DRG Regulation Opponents May Have Powerful New Ally

This article is from The Cancer Letter archive.

Vol. 09 No. 45 | November 25, 1983

Download PDF Visit The Full Archive

Related Articles

NCI’s SBIR Awards Move Up In Quality; Congress considers Making It Permanent; FASEB Object

September 19, 1986

Drug Shortages: Institutions Report Halting Enrollment in Clinical Trials

March 22, 2013

In Brief: Hong to Retire After 30 Years at MD Anderson

February 14, 2014

New Therapeutic Options Enhance Breast Cancer Treatment: ASCO Reports

July 26, 2002

ASCO Highlights Seven of 4,000 Abstracts Submitted for Annual Meeting, June 3-7

May 27, 2011

FASEB Urges Better Funding, Management Of Biomedical Research

February 23, 1996